agena-bioscience-logo
  • Products
  • Applications
  • Customer Success
  • Company
  • Contact
EN - Global CN - 中国

menu

agena-bioscience-logo agena-bioscience-logo Close
  • Home
  • Products
    • System
    • Panels
  • Applications
    • Pharmacogenetics
    • Liquid Biopsy
    • Tumor Profiling
    • SARS-CoV-2 Testing
    • Sample Integrity
    • Specimen Validity
    • Hereditary Genetics
    • Methylation
    • Chimerism
    • Blood Typing
  • Customer Success
  • Services
    • Assays by Agena
    • Insights Reporting Partners
    • Certified Service Providers
  • Resources
    • Videos & Webinars
    • Product Literature
    • Publication Library
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Careers
    • Press
  • Contact
  • Customer Support Portal
  • Home
  • Products
    • System
    • Panels
  • Applications
    • Pharmacogenetics
    • Liquid Biopsy
    • Tumor Profiling
    • SARS-CoV-2 Testing
    • Sample Integrity
    • Specimen Validity
    • Hereditary Genetics
    • Methylation
    • Chimerism
    • Blood Typing
  • Customer Success
  • Services
    • Assays by Agena
    • Insights Reporting Partners
    • Certified Service Providers
  • Resources
    • Videos & Webinars
    • Product Literature
    • Publication Library
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Careers
    • Press
    • Seminars & Webinars
  • Contact
  • Customer Support Portal

Phone: (858) 882-2800

Home / Resources / Publication Library

Search Results for: Liquid Biopsy

Search All publications

How recent?
  • Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors
  • Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
  • Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel
  • Recent Developments in Mutation Enrichment and Detection Technologies
  • Molecular Pathology in the New Age of Personalized Medicine
  • Emerging Role of Circulating Tumour DNA in Treatment Response Prognosis in Colon Cancer
  • Multiplex technologies for the assessment of minimal residual disease and low-level mutation detection in leukaemia: mass spectrometry versus next-generation sequencing
  • A pan-Canadian validation study for the detection of EGFR T790M mutation using circulating tumour DNA (ctDNA) from peripheral blood
  • Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients
  • The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)
12345...»
Company
  • About Us
  • Careers
  • Contact
Resources
  • Video Library
  • ISO Certifications
  • Clinical Approval
  • Patents
    Customer Support
    • Customer Support Portal
    • Support Contacts
Agena Bioscience

4755 Eastgate Mall,
San Diego, CA 92121

p. (858) 882-2800,  f. (858) 882-2727

With exception of the MassARRAY Dx, all other products are For Research Use Only. Not for use in diagnostic procedures.
© 2020-2022 Agena Bioscience, Inc. All rights reserved. Agena Bioscience is a subsidiary of Mesa Labs, Inc.

  • Privacy Policy
  • Website Terms & Conditions
  • Product Terms & Conditions
  • Warranty